Crossmark

Effects of upadacitinib or adalimumab on pain in rheumatoid arthritis and psoriatic arthritis: results from randomised phase 3 studies

Crossref DOI link: https://doi.org/10.1136/rmdopen-2025-005867

Published Online: 2026-01-08

Published Print: 2026-01

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Taylor, Peter C https://orcid.org/0000-0001-7766-6167
Kavanaugh, Arthur

Bessette, Louis

Fautrel, Bruno https://orcid.org/0000-0001-8845-4274
Takeuchi, Tsutomu https://orcid.org/0000-0003-1111-8218
Garrison, Andrew

Gao, Tianming

Lippe, Ralph

Caballero, Diane

Phillips, Charles

Mease, Philip J https://orcid.org/0000-0002-6620-0457
Funding

Funding for this research was provided by:

AbbVie Inc
License Information

License valid from 2026-01-08